Results 1 to 10 of about 436,469 (231)

Early risk assessment for COVID-19 patients from emergency department data using machine learning

open access: yesScientific Reports, 2021
Since its emergence in late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic with more than 55 million reported cases and 1.3 million estimated deaths worldwide.
Frank S. Heldt   +18 more
doaj   +1 more source

Defining the therapeutic reference range for cariprazine

open access: yesEuropean Psychiatry, 2023
Introduction According to the Consensus Guideline, the “therapeutic reference range” (TRR) defines ranges of drug blood concentrations that specify a lower limit below which a drug-induced therapeutic response is unlikely to occur and an upper limit ...
M. Kapás   +4 more
doaj   +1 more source

Pertussis Toxin-sensitive Activation of Phospholipase C by the C5a and fMet-Leu-Phe Receptors [PDF]

open access: yes, 1996
Signal transduction pathways that mediate C5a and fMet-Leu-Phe (fMLP)-induced pertussis toxin (PTx)-sensitive activation of phospholipase C (PLC) have been investigated using a cotransfection assay system in COS-7 cells.
Jiang, Huiping   +5 more
core   +1 more source

PLC

open access: yes, 2021
What do PLCs do?
openaire   +2 more sources

Similarity-based prediction of ejection fraction in heart failure patients

open access: yesInformatics in Medicine Unlocked, 2022
Biomedical research is increasingly employing real world evidence (RWE) to foster discoveries of novel clinical phenotypes and to better characterize long term effect of medical treatments.
Jamie Wallis   +4 more
doaj   +1 more source

A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study

open access: yesArthritis Research & Therapy, 2022
Background Publications suggest immunomodulation co-therapy improves responder rates in uncontrolled/refractory gout patients undergoing pegloticase treatment.
John K. Botson   +13 more
doaj   +1 more source

Large UK retailers' initiatives to reduce consumers' emissions: a systematic assessment [PDF]

open access: yes, 2017
In the interest of climate change mitigation, policy makers, businesses and non-governmental organisations have devised initiatives designed to reduce in-use emissions whilst, at the same time, the number of energy-consuming products in homes, and ...
Abrahamse   +148 more
core   +1 more source

Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis

open access: yesRespiratory Research, 2020
Background Patients with chronic obstructive pulmonary disease (COPD) are at risk of exacerbations and pneumonia; how the risk factors interact is unclear.
Benjamin F. Hartley   +5 more
doaj   +1 more source

Ezrin-related phosphoinositide pathway modifies RhoA and Rac1 in human osteosarcoma cell lines [PDF]

open access: yes, 2015
Selected Phosphoinositide-specific Phospholipase C (PI-PLC) enzymes occupy the convergence point of the broad range of pathways that promote Rho and Ras GTPase mediated signalling, which also regulate the activation of ezrin, a member of the ezrin ...
DELLA ROCCA, Carlo   +2 more
core   +1 more source

Color Octet Contribution to $J/\psi$ Production at a Photon Linear Collider [PDF]

open access: yes, 1998
We investigate $J/\psi$ production at a Photon Linear Collider (PLC) in the framework of NRQCD factorization approach. It was shown that color octet contribution is dominating in charmonium production at PLC.
A Tkabladze   +20 more
core   +3 more sources

Home - About - Disclaimer - Privacy